Interesting. Does this mean Dr. Fadiran and/or Dr. Laniyonu are out? How many people in regulatory affairs does a tiny biotech company need? I’m still trying to figure out how Fadiran and Laniyonu spend a combined 70+ hours a week. There just isn’t enough going in regulatory affairs to employ two people full time let alone three. Something just isn’t right about this.
We’ll have to watch the About page of the Anavex website to see if any additions and/or subtractions are made.